In line with ACR recommendations, allopurinol is strongly advised as a first-line urate-decreasing medication. Genetic tests is recommended (for a variant known as HLA B*5801) prior to setting up allopurinol since the carriers of this gene are at a heightened threat of the intense allergic reaction.Penyelidikan lanjutan sangat berkemungkinan member